Literature DB >> 10639237

Does Lethal Myocardial Reperfusion Injury Exist?

.   

Abstract

Year:  1997        PMID： 10639237     DOI： 10.1023/a:1017523123795

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  12 in total

1.  Interstitial equilibration of superoxide dismutase correlates with its protective effect in the isolated rabbit heart.

Authors:  B A Omar; J M McCord
Journal:  J Mol Cell Cardiol       Date:  1991-02       Impact factor: 5.000

2.  Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction.

Authors:  Y Murohara; Y Yui; R Hattori; C Kawai
Journal:  Am J Cardiol       Date:  1991-04-01       Impact factor: 2.778

3.  Cardioprotection by Cu,Zn-superoxide dismutase is lost at high doses in the reoxygenated heart.

Authors:  B A Omar; N M Gad; M C Jordan; S P Striplin; W J Russell; J M Downey; J M McCord
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

4.  Direct measurement of free radical generation following reperfusion of ischemic myocardium.

Authors:  J L Zweier; J T Flaherty; M L Weisfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.

Authors:  L G Chi; Y Tamura; P T Hoff; M Macha; K P Gallagher; M A Schork; B R Lucchesi
Journal:  Circ Res       Date:  1989-04       Impact factor: 17.367

6.  Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.

Authors:  J T Flaherty; B Pitt; J W Gruber; R R Heuser; D A Rothbaum; L R Burwell; B S George; D J Kereiakes; D Deitchman; N Gustafson
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

7.  Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.

Authors:  G Ambrosio; M L Weisfeldt; W E Jacobus; J T Flaherty
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

8.  Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase.

Authors:  H P Grill; J L Zweier; P Kuppusamy; M L Weisfeldt; J T Flaherty
Journal:  J Am Coll Cardiol       Date:  1992-12       Impact factor: 24.094

9.  Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium.

Authors:  J L Zweier; B K Rayburn; J T Flaherty; M L Weisfeldt
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

10.  Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.

Authors:  G Ambrosio; L C Becker; G M Hutchins; H F Weisman; M L Weisfeldt
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690
View more
  1 in total

1.  Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy.

Authors:  Mao Yang; Ningning Xi; Meng Gao; Yanwei Yu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.